Search
News
Monitoring COVID-19 vaccination progress across Europe
Following the conditional marketing authorisation and deployment of the first COVID-19 vaccines in the EU/EEA, all countries have started vaccination campaigns by vaccinating people in priority groups. To monitor the progress of vaccination efforts across the EU/EEA, ECDC has set up a monitoring system for collection of key vaccine rollout indicators.
Peer-Reviewed Publication
Strengthening screening for infectious diseases and vaccination among migrants in Europe: What is needed to close the implementation gaps?
Noori, T., Hargreaves, S., Greenaway, C., van der Werf, M., Driedger, M., Morton, R.L., Hui, C., Requena-Mendez, A., Agbata, E., Myran, D.T., Pareek, M., Campos-Matos, I., Nielsen, R.T., Semenza, J., Nellums, L.B., Pottie, K.
Data
Vaccination coverage for first dose of a measles- and rubella-containing vaccine, EU/EEA, 2018
Vaccination coverage for first dose of a measles- and rubella-containing vaccine, EU/EEA, 2018
Publication
COVID-19 vaccination and prioritisation strategies in the EU/EEA
This document builds on a previously published ECDC report, ‘Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK’ [15]. By using mathematical modelling, this document provides EU/EEA countries with information on factors that may affect the choice of COVID-19 vaccination
Peer-Reviewed Publication
Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines
Sturkenboom, M., Bahri, P., Chiucchiuini, A., Grove Krause, T., Hahné, S., Khromava, A., Kokki, M., Kramarz, P., Kurz, X., Larson, H.J., de Lusignan, S., Mahy, P., Torcel-Pagnon, L., Titievsky, L., Bauchau, V.
News
ECDC releases COVID-19 vaccination rollout strategies for EU/EEA
On 22 December ECDC released the technical report titled ‘COVID-19 vaccination and prioritisation strategies in the EU/EEA’, following the European Medicines Agency (EMA) recommendation for authorisation of the vaccine Comirnaty, developed by BioNTech and Pfizer.
News
First COVID-19 vaccine authorised for use in the European Union
ECDC welcomes the authorisation of the first vaccine against COVID-19 in EU/EEA. We have been looking forward to this moment for a long time.
On 21 December, EMA recommended granting a conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. On the same day, the European Commission has granted market authorisation for EU-wide use.
Publication
Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK
This document provides an overview of the key aspects related to the initial phases following the introduction of one or more COVID-19 vaccines in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK). The aim is to support but not define EU policy on COVID-19 vaccination.
Data
Video on COVID-19 vaccination in the EU/EEA and the UK
It's not known when potential COVID-19 #vaccines will be available for use in the EU/EEA and the UK, but supply is likely to be limited in the early stages. Countries will therefore need to develop a vaccination strategy and identify priority groups for #vaccination.
Event
Flu Awareness Week, 5-9 October 2020
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.